ArticleThe Journal of clinical investigation2019

Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma.

Niraj Shenoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.